PATENT CLAIM ANALYSIS

Application Number: 16136191
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["536", "024500"]

Abstract:
The present invention concerns methods and reagents useful in modulating gene expression in a variety of applications, including use in therapeutic, diagnostic, target validation, and genomic discovery applications. Specifically, the invention relates to synthetic chemically modified small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules capable of mediating RNA interference (RNAi) against target nucleic acid sequences. The small nucleic acid molecules are useful in the treatment of any disease or condition that responds to modulation of gene expression or activity in a cell, tissue, or organism.

Claim (Index 10):
A composition comprising the siRNA molecule of  claim 1  and a pharmaceutically acceptable carrier or diluent.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 97.0
- Lexical Diversity: 1.83099
- Patent Class: 536.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14514112', '10720448', '13480655', '14731346', '15677719']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7752471903574164
- 35 USC 102 Novelty (BERT): 0.7153624694331543
- Combined Prediction Score: 0.7692587182649901
- Mean Citation Score: 752.0730120000003
- Max Citation Score: 759.4065
- Similarity Product: 731.2316006032527

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test